Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (TCTR20260721003) titled 'The Individualized Medication Adherence Program for People with Schizophrenia Dwelling in the Community' on July 21.
Study Type: Interventional
Study Design:
Randomized
Primary Sponsor: Lia Endriyani
Condition:
Schizophrenia
Medication non-adherence
Schizophrenia
Medication Adherence
Antipsychotics Medication
Community Mental Health
Schizophrenia
Medication Adherence
Antipsychotics Medication
Community Mental Health
Intervention:
Participants received the Individualized Medication Adherence Program (IMAP) in addition to standard care provided by the primary healthcare centers. IMAP is an individualized beha...